In conclusion, the systematic evaluation of DRD and SSTR expression in somatotropinomas has revealed an association between the response to SSAs treatment and DRD4, DRD5, SSTR1 and SSTR2 expression. This evidence concerns the gene DRD5 and growth hormone-producing pituitary gland neoplasm.